Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1896
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists” ; volume:14 ; number:1 ; day:30 ; month:12 ; year:2015 ; pages:117-118 ; date:2.2016
Applied health economics and health policy ; 14, Heft 1 (30.12.2015), 117-118, 2.2016
- Urheber
-
Samuelsen, Carl
Bateman, Eric D.
Pavord, Ian
Lloyd, Adam
Baldwin, Mike
Esser, Dirk
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40258-015-0215-0
- URN
-
urn:nbn:de:101:1-2019070518592477306103
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Samuelsen, Carl
- Bateman, Eric D.
- Pavord, Ian
- Lloyd, Adam
- Baldwin, Mike
- Esser, Dirk
- SpringerLink (Online service)
Ähnliche Objekte (12)
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Pharmacokinetic and pharmacodynamic characterization of inhaled β2-agonists [beta-2-agonists] using the isolated human lung perfusion model
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Pharmacokinetic and pharmacodynamic characterization of inhaled β2-agonists [beta-2-agonists] using the isolated human lung perfusion model
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Pharmacokinetic and pharmacodynamic characterization of inhaled β2-agonists [beta-2-agonists] using the isolated human lung perfusion model
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma